Clinical effectiveness and safety of low cost versus innovator brand amlodipine in hypertension: A single-blinded, randomized, crossover, noninferiority trial

OBJECTIVES: A single-blinded, randomized, crossover, noninferiority trial was conducted to evaluate clinical effectiveness and safety of low-cost brand (LCB) versus innovator brand (IB) amlodipine in essential hypertension. MATERIALS AND METHODS: The primary end-point was change of systolic blood pr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Indian J Pharmacol
Main Authors: Das, Alak Kumar, Chatterjee, Suparna, Pal, Jyotirmoy
Format: Artigo
Jezik:Inglês
Izdano: Medknow Publications & Media Pvt Ltd 2016
Teme:
Short Communication
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5155474/
https://ncbi.nlm.nih.gov/pubmed/28066111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.194844
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki